statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (MyMD) a clinical stage biopharmaceutical...

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

PharmaCyte Biotech, Inc. (NASDAQ:PMCB  Get Free Report)s stock price dropped 1.6% during mid-day trading on Tuesday . The stock traded as low as $2.34 and last traded at $2.44...

PharmaCyte Biotech (NASDAQ:PMCB) Trading Down 1.6%

PharmaCyte Biotech, Inc. (NASDAQ:PMCB  Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 26,500 shares, a...

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Sees Significant Drop in Short Interest

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

PharmaCyte Biotech Inc

Watchers	5,828
52-Wk Low	$1.92
52-Wk High	$3.23

Volume	5,009.00
52-Wk High	$3.23
52-Wk Low	$1.92

Period	Estimated	Reported	Surprise	Result
Q4'22	--	-$0.09	--	N/A
Q3'22	--	-$0.08	--	N/A
Q2'22	-$0.08	-$0.08	--	EXPECTED
Q1'22	-$0.07	-$0.07	--	EXPECTED

PMCB PharmaCyte Biotech Inc

About

Feed

News

Earnings

Fundamentals